Acinetobacter baumannii: Epidemiological and beta-lactamase data from two tertiary academic hospitals in Tshwane, South Africa

Frontiers in Microbiology

Volumn 9, Issue JUN, 2018, Pages

  Lowe, Michelle ^a   Ehlers, Marthie M ^a,b   Ismail, Farzana ^a,b   Peirano, Gisele ^c,d   Becker, Piet J ^a   Pitout, Johann D D ^a,c,d   Kock, Marleen M ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c UNIVERSITY OF CALGARY   (Canada)

^d CALGARY LABORATORY SERVICES   (Canada)

Author keywords

Acinetobacter baumannii; BlaOXA 23 like; MDR; MLST; PFGE; South Africa

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE OXA 23 LIKE; BETA LACTAMASE OXA 58 LIKE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; FEMALE; GENE IDENTIFICATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; MALE; MEDICATION OVERUSE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AFRICA; TERTIARY CARE CENTER;

EID: 85048350958     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.01280     Document Type: Article

References (63)

1. Adams-Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G. B., Marschall, J., Urban, C. M., et al. (2011). Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49, 3849-3854. doi: 10.1128/JCM.00619-11
2. Agodi, A., Voulgari, E., Barchitta, M., Quattrocchi, A., Bellocchi, P., Poulou, A., et al. (2014). Spread of a carbapenem-and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J. Hosp. Infect. 86, 260-266. doi: 10.1016/j.jhin.2014.02.001
3. Asai, S., Umezawa, K., Iwashita, H., Ohshima, T., Ohashi, M., Sasaki, M., et al. (2014). An outbreak of blaOXA-51-like and blaOXA-66 positive Acinetobacter baumannii ST208 in the emergency intensive care unit. J. Med. Microbiol. 63, 1517-1523. doi: 10.1099/jmm.0.077503-0
4. Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., and Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 49, 4382-4390. doi: 10.1128/JCM.43.9.4382-4390.2005
5. Cai, Y., Chai, D., Wang, R., Liang, B., and Bai, N. (2012). Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J. Antimicrob. Chemother. 67, 1607-1615. doi: 10.1093/jac/dks084
6. Cicek, A. C., Saral, A., Iraz, M., Ceylan, A., Duzgun, A. O., Peleg, A. Y., et al. (2014). OXA-and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates form a Turkish university hospital. Clin. Microbiol. Infect. 20, 410-415. doi: 10.1111/1469-0691.12338
7. Clímaco, E. C., de Oliveira, M. L., Pitondo-Silva, A., Oliveira, M. G., Medeiros, M., Lincopan, N., et al. (2013). Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil. Infect. Genet. Evol. 19, 127-133. doi: 10.1016/j.meegid.2013.06.024
8. Clinical and Laboratory Standards Institute [CLSI] (2017). Performance Standards for Antimicrobial Susceptibility Testing-Twenty Seven Edition. CLSI Supplement M100. Wayne, PA: CLSI
9. Cooper, J. E., and Feil, E. J. (2004). Multilocus sequence typing-what is resolved? Trends Microbiol. 8, 373-377. doi: 10.1016/j.tim.2004.06.003
10. Correa, A., del Campo, R., Escandón-Vargas, K., Perenguez, M., Rodríguez-Baños, M., Hernández-Gómez, C., et al. (2017). Distinct genetic diversity of carbapenem-resistant Acinetobacter baumannii from Colombian hospitals. Microb. Drug Resist. 24, 48-54. doi: 10.1089/mdr.2016.0190
11. Dijkshoorn, L., Nemec, A., and Seifert, H. (2007). An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939-951. doi: 10.1038/nrmicro1789
12. Endo, S., Yano, H., Hirakata, Y., Arai, K., Kanamori, H., Ogawa, M., et al. (2012). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J. Antimicrob. Chemother. 67, 1623-1626. doi: 10.1093/jac/dks094
13. EUCAST (2016). Recommendations for Mic Determination of Colistin (Polymyxin E) as Recommended by the Joint CLSI-EUCAST Polymyxin Breakpoints Working Group. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/Recommendations_for_MIC_determination_of_colistin_March_2016.pdf [accessed April 06, 2018]
14. Evans, B. A., and Amyes, S. G. B. (2014). OXA β-lactamases. Clin. Microbiol. Rev. 27, 241-263. doi: 10.1128/CMR.00117-13
15. Fang, Y., Quan, J., Hua, X., Feng, Y., Li, X., Wang, J., et al. (2016). Complete genome sequence of Acinetobacter baumannii XH386 (ST208), a multi-drug resistant bacteria isolated from pediatric hospital China. Genom. Data 7, 269-274. doi: 10.1016/j.gdata.2015.12.002
16. Feizabadi, M. M., Fathollahzadeh, B., Taherikalani, M., Rasoolinejad, M., Sadeghifard, N., Aligholi, M., et al. (2008). Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61, 274-278
17. Field, N., Cohen, T., Struelens, M. J., Palm, D., Cookson, B., and Glynn, J. R. (2014). Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect. Dis. 14, 341-352. doi: 10.1016/S1473-3099(13)70324-4
18. Fillaux, J., Dubouix, A., Concil, J. M., Laguerre, J., and Marty, N. (2006). Retrospective analysis of multidrug-resistant Acinetobacter baumannii strains isolated during a 4-year period in a university hospital. Infect. Control Hosp. Epidemiol. 27, 647-653. doi: 10.1086/507082
19. Fouad, M., Attia, A. S., Tawakkol, W. M., and Hashem, A. M. (2013). Emergence of carbapenem-resistant Acinetobacter baumannii harbouring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int. J. Infect. Dis. 17, e1252-e1254. doi: 10.1016/j.ijid.2013.07.012
20. Fu, Y., Zhou, J., Zhou, H., Yang, Q., Wei, Z., Yu, Y., et al. (2010). Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J. Antimicrob. Chemother. 65, 644-650. doi: 10.1093/jac/dkq027
21. Ghaith, D. M., Zafer, M. M., Al-Agamy, M. H., Alyamani, E. J., Booq, R. Y., and Almoazzamy, O. (2017). The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital. Ann. Clin. Microbiol. Antimicrob. 16:34. doi: 10.1186/s12941-017-0208-y
22. Grundmann, H. J., Towner, K. J., Dijkshoorn, L., Gerner-Smidt, P., Maher, M., Seifert, H., et al. (1997). Multicenter study is using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobater spp. J. Clin. Microbiol. 35, 3071-3077
23. Hammoudi, D., Moubareck, C. A., and Sarkis, D. K. (2014). How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. J. Microb. Methods 107, 106-118. doi: 10.1016/j.mimet.2014.09.009
24. Hamouda, A., Evans, B. A., Towner, K. J., and Amyes, S. G. B. (2010). Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis and sequence-based typing of blaOXA-51-like genes. J. Clin. Microbiol. 48, 2476-2483. doi: 10.1128/JCM.02431-09
25. Hu, Y., Li, B., Jin, D., Cui, Z., Tao, X., Zhang, B., et al. (2013). Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of Acinetobacter baumannii in China. J. Clin. Microbiol. 51, 1263-1268. doi: 10.1128/JCM.03108-12
26. Huang, G., Yin, S., Gong, Y., Zhao, X., Zou, L., Bei, J., et al. (2016). Multilocus sequence typing analysis of carbapenem-resistant Acinetobacter baumannii in a Chinese burns institute. Front. Microbiol. 7:1717. doi: 10.3389/fmicb.2016.01717
27. Jacobs, A. C., Thompson, M. G., Black, C. C., Kessler, J. L., Clark, L. P., McQueary, C. N., et al. (2014). AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5:e01076-14. doi: 10.1128/mBio.01076-14
28. Jeon, H., Kim, S., Kim, M. H., Kim, S. Y., Nam, D., Park, S. C., et al. (2018). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospital that carry blaOXA-23. Infect. Genet. Evol. 58, 232-236. doi: 10.1016/j.meegid.2018.01.003
29. Kim, D. H., Jung, S., Kwon, K. T., and Ko, K. S. (2017). Occurrence of diverse AbGTI1-type genomic islands in Acinetobacter baumannii global clone 2 isolates from South Korea. Antimicrob. Agents Chemother. 61:e01972-16. doi: 10.1128/AAC.01972-16
30. Kock, M. M., Bellomo, A. N., Storm, N., and Ehlers, M. M. (2013). Prevalence of carbapenem resistance genes in Acinetobacter baumannii isolated from clinical specimens obtained from an academic hospital in South Africa. South Afr. J. Epidemiol. Infect. 28, 28-32. doi: 10.1080/10158782.2013.11441516
31. Kuo, S. C., Yang, S. P., Lee, Y. T., Chuang, H. C., Chen, C. P., Chang, C. L., et al. (2013). Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne blaOXA-72 in Taiwan. BMC Infect. Dis. 13:319. doi: 10.1186/1471-2334-13-319
32. Lean, S., Suhaili, Z., Ismail, S., Rahman, N. I. A., Othman, N., Abdullah, F. H., et al. (2014). Prevalence and genetic characterization of carbapenem-and polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in Terengganu, Malaysia. ISRN Microbiol. 2014, 1-9. doi: 10.1155/2014/953417
33. Lean, S. S., Yeo, C. C., Suhaili, Z., and Thong, K. L. (2015). Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 cline from Malaysia. Int. J. Antimicrob. Agents 45, 178-182. doi: 10.1016/j.ijantimicag.2014.10.015
34. Lee, H., Huang, C., Chen, C., Wang, Y., Chang, C., and Chiu, C. (2015). Emergence in Taiwan of novel Imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients. J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2015.04.001 [Epub ahead of print]
35. Lee, S. Y., Shin, J. H., Park, K. H., Kim, J. H., Shin, M. G., Suh, S. P., et al. (2014). Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a University hospital. J. Clin. Microbiol. 52, 931-939. doi: 10.1128/JCM.02868-13
36. Liakopoulos, A., Miriagou, V., Katsifas, E. A., Karagouni, A. D., Daikos, G. L., Tzouvelekis, L. S., et al. (2012). Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill. 17:20117
37. Lowings, M., Ehlers, M. M., Dreyer, A. W., and Kock, M. M. (2015). High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa-an update. BMC Infect. Dis. 15, 521-530. doi: 10.1186/s12879-015-1246-8
38. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an internal expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x
39. Maragakis, L. L., and Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobialresistance, and treatment options. Clin. Infect. Dis. 46, 1254-1263. doi: 10.1086/529198
40. Mavroidi, A., Likousi, S., Palla, E., Katsiari, M., Roussou, Z., Maguina, A., et al. (2015). Molecular identification of tigecycline-and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013. J. Med. Microbiol. 64, 993-997. doi: 10.1099/jmm.0.000127
41. Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., and Jones, R. N. (2009). Emergence and widespread dissemination of OXA-23,-24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63, 55-59. doi: 10.1093/jac/dkn434
42. Patel, G., and Bonomo, R. A. (2013). Stormy waters ahead': global emergence of carbapenemases. Front. Microbiol. 4:48. doi: 10.3389/fmicb.2013.00048
43. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582. doi: 10.1128/CMR.00058-07
44. Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., and Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471-3484. doi: 10.1128/AAC.01464-06
45. Pfeifer, Y., Trifonova, A., Pietsch, M., Brunner, M., Todorova, I., Gergova, I., et al. (2017). Clonal transmission of Gram-negative bacteria with carbapenemases NDM-1, VIM-1 and OXA-23/72 in a Bulgarian Hospital. Microb. Drug Resist. 23, 301-307. doi: 10.1089/mdr.2016.0059
46. Potron, A., Poirel, L., and Nordmann, P. (2015). Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int. J. Antimicrob. Agents 45, 568-585. doi: 10.1016/j.ijantimicag.2015.03.001
47. Pournaras, S., Poulou, A., Dafopoulou, K., Chabane, Y. N., Kristo, I., Makris, D., et al. (2014). Growth retardation, reduced invasiveness and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii. Antimicrob. Agents Chemother. 58, 828-832. doi: 10.1128/AAC.01439-13
48. Qu, J., Du, Y., Yu, R., and Lü, X. (2016). The first outbreak caused by Acinetobacter baumannii ST208 and ST195 in China. Biomed Res. Int. 2016:9254907. doi: 10.1155/2016/9254907
49. Ribot, E. M., Fair, M. A., Gautom, R., Cameron, D. N., Hunter, S. B., Swaminathan, B., et al. (2006). Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella and Shigella for PulseNet. Foodborne Pathog. Dis. 3, 59-67. doi: 10.1089/fpd.2006.3.59
50. Saffari, F., Monsen, T., Karmostaji, A., Azimabad, F. B., and Winderström, M. (2017). Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in Southern Iran. J. Med. Microbiol. 66, 1656-1662. doi: 10.1099/jmm.0.000619
51. Salimizand, H., Noori, N., Meshkat, Z., Ghazvini, K., and Amel, S. J. (2015). Prevalence of Acinetobacter baumannii harbouring ISAba/blaOXA-23-like family in a burn center. Burns 41, 1100-1106. doi: 10.1016/j.burns.2014.12.008
52. Sekyere, J. O. (2016). Current state of resistance to antibiotics of last-resort in South Africa: a review from a public health perspective. Front. Public Health 4:209. doi: 10.3389/fpubh.2016.00209
53. Sousa, C., Botelho, J., Grosso, F., Silva, L., Lopes, J., and Peixe, L. (2015). Unsuitability of MALDO-TOF MS to discriminate Acinetobacter baumannii clones under routine experimental conditions. Front. Microbiol. 6:481. doi: 10.3389/fmicb.2015.00481
54. Tamayo-Legorreta, E., Turrubiartes-Martínez, E., Garza-Ramos, U., Niño-Moreno, P.,Barrios, H., Sánchez-Pérez, A., et al. (2016). Outbreak caused by blaOXA-72 producing Acinetobacter baumannii ST417 detected in clinical and environmental isolates. Microb. Drug Resist. 22, 129-133. doi: 10.1089/mdr.2015.0157
55. Tan, S. Y., Chua, S. L., Liu, Y., Høiby, N., Andersen, L. P., Givskov, M., et al. (2013). Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone. Genome Biol. Evol. 5, 807-818. doi: 10.1093/gbe/evt047
56. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239
57. Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., and Pitt, T. L. (2006). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976. doi: 10.1128/JCM.01021-06
58. Vijayakumar, S., Gopi, R., Gunasekaran, P., Bharathy, M., Walia, K., Anandan, S., et al. (2016). Molecular characterization of invasive carbapenem resistant Acinetobacter baumannii from a tertiary care hospital in South India. Infect. Dis. Ther. 5, 379-387. doi: 10.1007/s40121-016-0125-y
59. Villalón, P., Valdezate, S., Medina-Pascual, M. J., Rubio, V., Vindel, A., and Saez-Nieto, J. A. (2011). Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. Clin. Microbiol. 49, 875-882. doi: 10.1128/JCM.01026-10
60. Voets, G. M., Fluit, A. C., Scharringa, J., Stuart, J. C., and Leverstein-Van Hall, M. A. (2011). A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int. J. Antimicrob. Agents 37, 356-359. doi: 10.1016/j.ijantimicag.2011.01.005
61. Wu, W., He, Y., Lu, J., Lu, Y., Wu, J., and Liu, Y. (2015). Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii clinical isolates in Southern China: an 8-year study. PLoS One 10:e0137174. doi: 10.1371/journal.pone.0137174
62. Yang, J. Y., Brooks, S., Meyer, J. A., Blakesley, R. R., Zelazny, A. M., Segre, J. A., et al. (2013). Pan-PCR, a computational method designing bacterium-typing assays based on whole-genome sequence data. J. Clin. Microbiol. 51, 752-758. doi: 10.1128/JCM.02671-12
63. Zowawi, H. M., Sartor, A. L., Sidjabat, H. E., Balkhy, H. H., Walsh, T. R., Al Johani, S. M., et al. (2015). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf cooperation council states: dominance of OXA-23-type producers. J. Clin. Microbiol. 53, 896-903. doi: 10.1128/JCM.02784-14